Jamey Lister

Jamey Lister, PhD (Rutgers University, 2014), is an associate professor at Rutgers, The State University of New Jersey within the School of Social Work. Dr. Lister’s scholarship targets health care solutions for addiction and behavioral health conditions faced by people living in medically underserved areas. He emphasizes practical treatment and policy implications, strategies to facilitate evidence-based care services, and methods tailored to population health needs. Dr. Lister’s teaching, partnerships, and research dissemination all center on improving health care practice across sectors. Having grown up in a rural, medically underserved, mental health professional shortage area of Michigan guides Dr. Lister’s scholarship and intention to promote trust with partners. Furthermore, this background informs his approach to provide mentored research pathways for students and early-career scholars.

Dr. Lister has been involved as Key Personnel on more than $18 million in prior and ongoing awards supported by the United States Department of Health and Human Services. On these projects, he directs research efforts for approximately $2.5 million in funds as Principal Investigator or Site PI. These large-scale, cross-sector projects utilize team science approaches to improve health care services for medically underserved populations through partnerships with federal sponsors, state health departments, cross-disciplinary collaborators, and medical centers implementing services. In his role, he oversees a team of full-time staff, graduate/undergraduate students, and Co-Investigators to collaboratively engage with these cross-sector partners. Dr. Lister also has experience leading research projects supported by philanthropic foundations, university funded initiatives, and has received awards from the National Institute on Drug Abuse, College on Problems of Drug Dependence, and U.S. Fulbright Program. Dr. Lister currently serves as the New Jersey Director and Co-Director for HHS Region 2 of SAMHSA's Northeast & Caribbean Rural Opioid Technical Assistance Center. He is also on the Advisory Board for HRSA’s Behavioral Health Excellence – Technical Assistance Center and has continuously served as a Convener for SSWR’s Rural Behavioral Health Special Interest Group since 2017.

Before joining the faculty at Rutgers University, Dr. Lister was at Wayne State University as a tenure-track faculty member, and prior to that, as a postdoctoral fellow. He earned his PhD from Rutgers University, MSW from the University of Michigan, and BS from Miami (Ohio) University. Dr. Lister’s full-time faculty positions, and each educational institution he earned degrees from, have been in social work programs at public research universities. Conversely, much of Dr. Lister’s training and collaborations involve partnerships with other disciplines (e.g., psychiatry, psychology, public health) and organizations (e.g., academic medical center sites, state health care systems, community-based) engaged in clinical practice for addiction.

• Advanced Contemporary Policy: Mental Health (19:910:587) (*starting Fall 2025)
• Reducing Drug Harm: Social Work Practice & Policy (19:910:570)
• Case Management in Addictions Practice (19:910:598)
• HBSE: Understanding Addictive Behaviors (19:910:514)
• Clinical Assessment & Diagnosis (19:910:507)
• Clinical Social Work II (19:910:512)
• Advanced Individual Studies in Social Welfare (19:910:682)
• Research in Social Work (16:910:701)
• Research in Social Work (16:910:702)

* = Served as Corresponding Author and/or Principal Investigator
** = student and postdoctoral authors

Lister, J.J.*, & Joudrey, P.J. (2023). Rural mistrust of public health interventions in the United States: A call for taking the long view to improve adoption. The Journal of Rural Health, 39(1), 18-20. Doi: 10.1111/jrh.12684

Lister, J.J.*, Lister, H.H., Powell, K.G., Cheung, S.P.**, Peterson, N.A., Toto, A.M., & Marcello, S.C. (2024). The Rutgers Integrated Care Evaluation (RICE) Research Framework: An innovative and rigorous set of methods to evaluate integrated care programs. International Journal of Integrated Care, 24(3): 22, 1-8. DOI: 10.5334/ijic.7715

Ware, O.D., Lister, J.J.*, Cooper, S.E.**, Kim, A.H.**, Lister, H.H., Peterson, N.A., Fioravanti, S., Powell, K.G., Marcello, S.C., & Joseph, B. (2025). Subtypes and service utilization patterns among opioid use disorder patients at a community health center: Findings from a medically underserved urban area of the Northeastern United States. Addiction Science & Clinical Practice, 20(39), 1-10. Doi: 10.1186/s13722-025-00564-z

Van der Maas, M., Lister, J.J.*, & Nower, L. (2025). Rural-urban comparison of gambling disorder treatment and recovery service availability in the United States: A hurdle model approach. Manuscript accepted at Journal of Social Work Practice in the Addictions, 1-14. Doi: 10.1080/1533256X.2025.2504571

Lister, J.J.*, Weaver, A., Ellis, J.D.**, Himle, J.A., & Ledgerwood, D.M. (2020). A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. The American Journal of Drug and Alcohol Abuse, 46(3), 273-288. Doi: 10.1080/00952990.2019.1694536

Lister, J.J.*, Ellis, J.D.**, Struble, C.A.**, Ledgerwood, D.M., & Greenwald, M.K. (2024). Protective factor predictors of abstinence and retention in patients receiving methadone treatment for opioid use disorder. International Journal of Mental Health and Addiction, 22, 615-633. Doi: 10.1007/s11469-022-00893-z

Lister, J.J.*, & Lister, H.H. (2021). Improving methadone access for rural communities in the USA: Lessons learned from COVID-19 adaptations and international models of care. Rural and Remote Health, 21(4), 6770. Doi: 10.22605/RRH6770

Struble, C.A.**, Lister, J.J.*, Urbiel, J.**, Nyaku, A.N., & Arfken, C.L. (2022). Comparisons of injection and non-injection opioid use among Black people in methadone treatment: A pilot in Detroit. Addictive Behaviors, 126, 107182, 1-5. Doi: 10.1016/j.addbeh.2021.107182

Lister, J.J.*, Ellis, J.D.**, & Yoon, M.** (2020). Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013-2017. Addictive Behaviors Reports, 11, 100234, 1-8. Doi: 10.1016/j.abrep.2019.100234

Lister, J.J.*, Lee, G.**, Ellis, J.D.**, Pasman, E.**, Agius, E., & Resko, S.M. (2022). Comorbid affective and substance use disorders of Medicaid/Medicare beneficiaries at an opioid treatment program serving small urban and rural communities. Frontiers in Psychiatry, 13, 881821, 1-9. Doi: 10.3389/fpsyt.2022.881821

Lister, J.J.*, Weaver, A., Ellis, J.D.**, Molfenter, T., Ledgerwood, D.M., & Himle, J.A. (2020). Shortages of medication-assisted treatment for opioid use disorder in underserved Michigan counties: Examining the influence of urbanicity and income level. Journal of Health Care for the Poor and Underserved, 31(3), 1291-1307. Doi: 10.1353/hpu.2020.0095

Lister, J.J.*, Yoon, M., Nower, L., Ellis, J.D., & Ledgerwood, D.M. (2022). Subtypes of patients with opioid use disorder in methadone maintenance treatment: A pathways model analysis. International Gambling Studies, 22(2), 300-316. Doi: 10.1080/14459795.2022.2044502

Lister, J.J.*, Brown, S., Greenwald, M.K., & Ledgerwood, D.M. (2019). Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic. Substance Abuse, 40, 185-193. Doi: 10.1080/08897077.2018.1547810

Lister, J.J.*, Greenwald, M.K., & Ledgerwood, D.M. (2017). Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone. Journal of Substance Use and Addiction Treatment, 78, 15-21. Doi: 10.1016/j.jsat.2017.04.007

Ellis, J.D.**, Lister, J.J.*, Wohl, M.J.A., Greenwald, M.K., Ledgerwood, D.M. (2023). Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder. Addictive Behaviors, 140, 107604, 1-6. Doi: 10.1016/j.addbeh.2022.107604

Crowthers, R.A.**, Arya, M.**, Venkataraman, A., Lister, J.J.*, Cooper, S.E.**, Enich, M.**, Bender, E., Stevens, S., Sanders, R., Stagliano, K., & Jermyn, R.T. (2022). Impact of an osteopathic peer recovery coaching model on treatment outcomes in high-risk men entering residential treatment for substance use disorders. Journal of Osteopathic Medicine, 122(10), 521-529. Doi: 10.1515/jom-2022-0066

Lister, H.H. Marcello, S., Lister, J.J., Toto, A.M., Powell, K.G., Peterson, N.A. (2022). Advancing the behavioral health workforce: An innovative integrated care and substance use disorder training model to improve outcomes for people in medically underserved communities. Families, Systems, & Health, 40(4), 586-591. Doi: 10.1037/fsh0000739

Pasman, E.**, Kollin, R., Broman, M.**, Lee, G.**, Agius, E., Lister, J.J., Brown, S., & Resko, S.M. (2022). Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addiction Science & Clinical Practice, 17, 35, 1-10. Doi: 10.1186/s13722-022-00316-3

Lloyd, J., Treitler, P.**, Lister, J.J., Nowels, M.**, & Crystal, S.C. (2024). Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic. Journal of Substance Use and Addiction Treatment, 167, 209476. Doi: 10.1016/j.josat.2024.209476

Broman, M.J.**, Pasman, E.**, Brown, S., Lister, J.J., Agius, E., & Resko, S.M. (2023). Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment. Addiction Research & Theory, 31(1), 37-44. Doi: 10.1080/16066359.2022.2101640

Ware, O.D., Lee, K.A., Lombardi, B., Buccio, D.L., Lister, J.J., Park, E., Estreet, A., Van Denise, T., Neukrug, H., Blank Wilson, A., Park, D., & Lanier, P. (2024). Artificial neural network analysis examining substance use problems co-occurring with anxiety and depressive disorders among adults receiving mental health treatment. Journal of Dual Diagnosis, 1-12. Doi: 10.1080/15504263.2024.2357623

Milano, N.**, Lister, J.J., & Victor, G. (2023). Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross-lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid use disorder. The American Journal on Addictions, 32, 352-359. Doi: 10.1111/ajad.13392

Sogbesan, A.**, Lenz, D., Lister, J.J., Lundahl, L.H., Greenwald, M.K., & Woodcock, E.A. (2024). Mediational pathways among drug use initiation, use-related consequences, and quit attempts. Drug and Alcohol Dependence Reports, 11, 100229, 1-7. Doi: 10.1016/j.dadr.2024.100229

Carl, A.**, Pasman, E.**, Broman, M.**, Lister, J.J., Agius, E., & Resko, S.M. (2023). Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone. Drug and Alcohol Dependence Reports, 6, 100138, 1-7. Doi: 10.1016/j.dadr.2023.100138

Victor, G., Hedden, B.J.**, Lister, J.J., Lee, G.**, Huynh, P., & Ray, B. (2023). Community overdose surveillance: Fentanyl involvement in overdose deaths in rural Michigan. Drug and Alcohol Dependence Reports, 7, 100150, 1-7. Doi: 10.1016/j.dadr.2023.100150